ev3 expects 2006 close for Micro Therapeutics buy-out:
This article was originally published in Clinica
Executive Summary
ev3 has inked the completion of its Micro Therapeutics (MTI) merger for January 6 2006. Plymouth, Minnesota-based ev3, which currently owns around 70% of MTI, announced in October this year it was to acquire all remaining shares of MTI in an all-stock transaction.